1,000+ M&A transactions for an aggregate value of $375+ billion since 2017
Cooley Stands Apart in Women and M&A Deal Leadership
Learn More
Cooley Bolsters Elite M&A Practice With Key Midwest Hire
Learn More
Cooley Shortlisted Across 15 Categories in The Deal’s Annual Awards
Learn More
Cooley Shortlisted for M&A Team of the Year at Legal Week’s British Legal Awards
Learn More
Cornerstone OnDemand Agrees to Sell to Clearlake Capital Group for $5.2 Billion
Learn More
Vividion Therapeutics Agrees to Sell to Bayer for up to $2 Billion
Learn More
Japan’s Paidy Agrees to Sell to PayPal for $2.7 Billion
Learn More
Kredivo Agrees to SPAC Merger With VPC Impact Acquisition Holdings II
Learn More
One Medical Agrees to Acquire Iora Health in $2.1 Billion Transaction
Learn More
Why Cooley
- 180+ member team in 17 major business and technology centers in the US, Europe and Asia
- Broad industry platform with clients across many industries and sophisticated capabilities in all practice areas
- Excel in deals in the tech, life sciences, medical device and healthcare, consumer, education, defense and media industries
- Given our market position in the medtech and life sciences sectors, we have handled a large number of life sciences M&A transactions, both public and private, and understand unique structuring issues for life sciences companies, including milestone structures, contingent value rights and option structures
- Primary corporate counsel to 200+ public companies, giving us an unmatched perspective on market deal points and ability to facilitate introductions between buyers and sellers
- Represent all categories of participants in transactions, including buyers, sellers, major stockholders, venture capitalists, lenders, financial advisors, management/founders, special board committees, individual investors, private equity funds, hedge funds and others
- Adept at handling all manner of transactions, including domestic and cross-border mergers and acquisitions, strategic deals including joint ventures, acquisitions of IP assets, patent cross-licenses, complex divestitures and spin-offs, takeover defense and shareholder activism counseling, and multibillion-dollar public company mergers
- Robust SPAC experience and thought leaders in the area with a repository of market insight and guidance for businesses interested in the IPO alternative @ SPACtivity
- Market-leading IP, privacy, technology licensing, life sciences collaborations and licensing, regulatory, government contracts, credit finance, private equity, antitrust, employment, compensation and tax practices to support transactions
Public Company Innovation Hub
Resources for forward-thinking board members and leaders of US-listed public companies
Visit hub
Recognition
- The Legal 500: Tier 2 M&A: Middle-Market (2020)
- Best Lawyers (National): Tier 1 M&A (2020)
- The American Lawyer: Tech Deal Firm of the Year (2020)
- PitchBook: #1 in VC-Backed Exits by count (M&A + IPO) (2020)
- Mergermarket: Top 10 in US M&A by count (2020)
- Mergermarket: Top 5 for M&A Exits (2020)
- The Deal: Top 12 M&A Law Firms Power Rankings by count (2020)
M&A Blog
Newsworthy developments in the global mergers and acquisitions space
View blog
ViewHide related contacts
+-
Listing Returned 0 Results.
-
{{ item.name }}
{{ item.title }}
{{ item.location }}{{ item.secondaryoffices}}
-
{{ item.name }}
{{ item.title }}
{{ item.location }}{{ item.secondaryoffices}}
ViewHide related news
+-
Listing Returned 0 Results.
ViewHide related events
+-
Listing Returned 0 Results.